Analysis of AR DNA-seq data demonstrated that 12/30 tumours (6/15 patients) in this metastatic CRPC cohort displayed AR gene amplification, which was defined as normalized coverage of the AR gene >1 when compared with normalized coverage at a set of control genomic regions (Fig. 1a and Supplementary Table 4). The gene discussed is AR; the disease is neoplasm.